IAV-Partikelimpfung - T-Zellvakzinierung von AAD Mäusen gegen das Influenza Virus mit biologisch abbaubaren Mikropartikeln, Studienteil Universität Konstanz
|
Project leader |
01.03.2021 – 31.12.2024 |
Spende Labor Dr. Brunner
|
Project leader |
30.07.2020 – 30.07.2020 |
Therapie des Prostatakarzinoms durch Inhibition des Immunoproteasoms
|
Project leader |
01.04.2020 – 30.09.2025 |
Regulation der 26S Proteasomaktivität und der Bewältigung von Proteinaggregationserkrankungen durch Nub1
|
Project leader |
01.09.2019 – 30.09.2024 |
The effect of immunoproteasome inhibition on monocyte survival, T cell activation, and generation of a conditional LMP7-deficient mouse to study immunoproteasome function in autoimmunity
|
Project leader |
01.02.2018 – 31.12.2023 |
Investigating immunoproteasome inhibition as a new therapeutic approach to prevent chronic antibody-mediated rejection of renal allgrafts
|
Project leader |
01.08.2017 – 31.01.2020 |
Tagung: The ubiquitin-like modeifier FAT 10 in immune regulation and cancer, 08./09. März 2017 in Rahovot, Israel
|
Project leader |
10.02.2017 – 31.12.2017 |
PRECIOUS
|
Project leader |
01.05.2016 – 31.10.2021 |
Identification of Immunoproteasome dependent factors involved in cytokine release an T cell differentiation
|
Project leader |
01.10.2013 – 09.02.2018 |
FlowKon
|
Project leader |
01.08.2013 – 31.10.2017 |
Validation of immunoproteasome subunits
|
Project leader |
01.08.2013 – 31.03.2017 |
Onyx Pharmaceuticals 2012/2013
|
Project leader |
01.09.2012 – 31.08.2013 |
SFB 969 TP C01: Die Substrate der FAT10ylierung und ihr Weg zum Abbau durch das Proteasom
|
Project leader |
01.01.2012 – 31.12.2023 |
The regulatory and functional network of ubiquitin family proteins - The role of the ubiquitin-like protein FAT10 in thymic slection
|
Project leader |
01.07.2011 – 30.06.2014 |
he function of immunoproteasomes in cytokine production and autoimmune diseases
|
Project leader |
01.11.2010 – 25.08.2014 |
Die Rolle des Immunproteasoms bei der Entstehung von Rheumatoider Arthritis, Diabetes und Psoriasis
|
Project leader |
01.07.2010 – 30.06.2012 |
The ubiquitin-like modifier FAT 10 in autophagosomal targeting
|
Project leader |
01.06.2010 – 31.05.2013 |
Conjugation Cascade and substrates of AT 10
|
Project leader |
14.05.2008 – 31.08.2012 |
The function of UBEIL2
|
Project leader |
11.04.2008 – 30.04.2013 |
Social stress and conflict resolution, Teilprojekt 3
|
Project leader |
01.04.2008 – 31.12.2011 |
Localization and intracellular trafficking of the chemokins receptor CCR7
|
Project leader |
20.03.2008 – 19.03.2013 |
The influence of social stress on the T Cell Respronse to viral infection
|
Project leader |
20.02.2008 – 31.07.2009 |
Immuntherapie des hormonresistenten Prostatakarzinoms
|
Project leader |
01.11.2007 – 30.06.2011 |
Proteasome molecular composition, biosynthesis, turnover and function during viral infection
|
Project leader |
06.07.2007 – 05.07.2008 |
Localization and intracellular trafficking of the chemokins receptor CCR7
|
Project leader |
12.06.2007 – 30.06.2008 |
The function and conjugation of the ubiquitin-like protein FAT10
|
Project leader |
27.06.2006 – 30.06.2009 |
The Mechanisms of cross-presentation of a long-lived viral protein
|
Project leader |
02.02.2006 – 01.02.2008 |
Proteasome molecular composition, biosynthesis, turnover and function during viral infection
|
Project leader |
15.04.2005 – 30.09.2008 |
Die Funktion des ubiquitin-ähnlichen Proteins FAT10 und seiner Überexpression in gastrointestinalen und gynäkologischen Tumoren
|
Project leader |
09.02.2005 – 31.01.2008 |
NUB-1 - a new interaction partner of the ubiquitin-like protein FAT10 with a novel function in proteolytic targeting
|
Project leader |
24.02.2004 – 30.05.2007 |
The function and conjugation of the ubiquitin-like protein FAT10
|
Project leader |
11.11.2002 – 20.02.2006 |